Search for: "Mylan Pharmaceuticals, Inc"
Results 281 - 300
of 498
Sort by Relevance
|
Sort by Date
12 Dec 2011, 9:59 pm
Mylan Pharmaceuticals Inc., an ANDA case brought before Judge Martini in the New Jersey District Court. [read post]
13 Nov 2011, 9:40 pm
• Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc. [read post]
31 Oct 2011, 6:46 am
They are also now big, big litigation.You might think that last week's decision in Hughes v Mylan, Inc., 2011 U.S. [read post]
28 Oct 2011, 7:00 am
Mylan Pharmaceuticals, Inc., 751 F. [read post]
21 Oct 2011, 7:40 am
The following is excerpted from an October 20, 2011 Mylan press release available on its website: Dey Pharma L.P., a subsidiary of Mylan Inc. [read post]
10 Oct 2011, 10:00 am
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
21 Sep 2011, 6:41 am
Mylan Bertek Pharmaceuticals, Inc., Civil No. 09-690 (JNE/JSM), 2010 WL 2519988 (D. [read post]
20 Sep 2011, 2:26 pm
In support, it cited Andrx Pharmaceuticals, Inc. v. [read post]
8 Sep 2011, 12:59 pm
Government Bloomberg News reports that Par Pharmaceutical Cos., a maker and distributor of generic drugs, engaged in an illegal drug- switching scheme to increase sales, the U.S. said in a lawsuit in which two Mylan Inc. units are also accused by a whistleblower of wrongdoing. [read post]
7 Sep 2011, 4:22 am
Apotex (Patently-O) Glivec (Imatinib mesylate) – India: The Glivec patent saga – its raining recusals (Spicy IP) Glivec (Imatinib mesylate) – India: Supreme Court to hear Novartis challenge to India’s patent law (IP Watch) Lo Loestrin Fe (Norethindrone acetate / Ethinyl estradiol / Ferrous fumarate) – US: Warner Chilcott files patent infringement complaint against Lupin in response to Para IV certification (Patent Docs) Lumigan (Bimatoprost) – US: Allergan files… [read post]
30 Aug 2011, 5:18 am
Mylan Inc., 09-8824, U.S. [read post]
29 Aug 2011, 5:53 am
After the Federal Circuit's decision in Thereasense, Inc. v. [read post]
27 Aug 2011, 7:55 pm
Mylan Labs., Inc., 464 F.3d 1286, 1289 (Fed. [read post]
24 Aug 2011, 12:33 am
The lobbying push for a PTE (FDA Law Blog) US: Generics fees: A fantastic opportunity (profitability through simplicity) USPTO announces agenda for next BCP customer partnership meeting (Patent Docs) US: GOP candidates unified in opposition to embryonic cell research (Patent Docs) US: District Court Massachusetts: Method of detecting fetal down syndrome passes muster under Bilski‘s machine-or-transformation test: PerkinElmer, Inc., et. al. v. [read post]
23 Aug 2011, 7:27 am
Mylan, Inc., 2011 U.S. [read post]
10 Aug 2011, 8:59 am
Mylan Pharmaceuticals Inc., C.A. [read post]
9 Aug 2011, 9:50 am
Mylan Pharmaceuticals, Inc., 696 F.Supp.2d 599 (N.D.W. [read post]
6 Aug 2011, 2:27 pm
.'s policy with Warren Funeral Chapel Inc. covered emotional distress under its definition of bodily injury. [read post]
5 Aug 2011, 12:29 pm
Manufacturers who have filed the appeal are: Actavis, Inc., Mylan, Inc., Teva Pharmaceutical Industries, and UDL Laboratories, Inc. [read post]
3 Aug 2011, 3:31 am
Patent and Trademark Office (Orange Book Blog) (IP Watch) (KEI) (Patent Docs) (Patent Docs) (IP Spotlight) (Patently-O) (Inventive Step) (Patentology) (Patent Law Practice Center) (IPBiz) (Out-Law) (PharmaPatents) (Maier & Maier) (Patent Docs) (Patent Baristas) Memantine – EU: CJEU ruling rejects pre-65/65 authorisations: Case C-195/09 Synthon v Merz Pharma (The SPC Blog) (EPLAW) Modafinil – UK: EWHC: Constructing a case for infringing particle-size patents: Cephalon Inc,… [read post]
